Search

Chronic rhinosinusitis management: back to the future?

Immunology is a dim and distant medical school memory to many ENT surgeons, but the increasingly complex immunology of chronic rhinosinusitis is fascinating (honestly!). Medical management options in CRS no longer just involves saline and steroids, and we need to...

TORS for patients with sleep-disordered breathing

Transoral robotic surgery is now a well-accepted technique in malignant tumours of the tongue base. Here the team from St Mary’s and the Royal National Throat Nose & Ear Hospital in London describe its use in carefully selected patients with...

Biologic therapies for chronic rhinosinusitis with nasal polyps: a new paradigm

Surgery for nasal polyposis has evolved significantly in the last 30 years, and now the medical management may be on the cusp of a revolution. Biologics using monoclonal antibodies to target specific immune pathways have introduced a paradigm shift in...

The integration of targeted therapy and surgery in advanced thyroid cancer clinical trials

One of the headline speakers, Mark Zafereo, will be talking at IFOS about thyroid cancer. We hear from his team about some of the areas they will be discussing. Locally advanced thyroid cancer generally refers to patients who have significant...

A brief overview on chronic facial pain in rhinology practice

Chronic facial pain is a common yet complex issue in rhinology, often neurologic in origin and frequently misattributed to sinus disease. Facial pain is a very common complaint in the rhinology clinic. In a community-based ENT practice where patient symptoms...

Paediatric vestibular evaluation

Richard E Gans is a renowned expert in the areas of vestibular evaluation and rehabilitation techniques. In the first of two articles (see here for the second article), Dr Gans gives an overview of the approach he and his team...

Congenital cytomegalovirus causing deafness in children: an update

Congenital CMV is the leading non-genetic cause of sensorineural hearing loss in children. Keith Trimble draws our attention to this and gives a comprehensive guide on diagnosis and treatment. Congenital cytomegalovirus (cCMV) infection is common, affecting 1% of all newborns,...

Patient-centred and accelerating progress: two organisations changing the landscape for rare skull base tumours

Patient-led organisations are transforming care for rare skull base tumours by connecting patients, clinicians and researchers to accelerate diagnosis, support and scientific progress. Askull base tumour diagnosis is a difficult time for any patient, but it is made more uncertain...

Cancer genetics and signalling pathways in ENT – a review and discussion of how this can be applied to rare tumours

Introduction Cancer cases continue to increase worldwide, and­­ head and neck cancer is a major global health issue, with an estimated global burden of over 630,000 new cases and over 350,000 deaths per year [1]. The term ‘head and neck...

AI reshaping the landscape of head and neck cancer

With artificial intelligence set to transform almost every aspect of life, Abishek Mahajan reviews its potential to improve head and neck cancer care. Artificial intelligence (AI) has emerged as a transformative tool in healthcare. In the realm of oncology, AI...

Why and what should hearing care professionals know about cognitive impairment and dementia

Good reasons to care about cognitive impairment and dementia in audiology If asking people what they fear most when getting to old age, it is cognitive decline that is named most often. This comes with the expectation of limitations in...

What you need to know about recent advances in genetics of hearing loss in the newborn

Identifying the underlying genetic cause of hearing loss in newborns can improve dramatically the early diagnosis and appropriate intervention. Hearing loss is the most common sensory disorder at birth, affecting approximately two out of 1000 newborns [1]. Congenital impaired hearing...